‹ All Posts
CA ATIN AGRRAWAL

7th Apr · SEBI-Registered Analyst

ABBOTINDIA

ABBOTINDIA
Abbott India Limited is one of the leading multinational pharmaceutical companies operating in India and is part of the global healthcare giant Abbott Laboratories. The company primarily sells branded generic medicines and healthcare products in India through distributors. Key therapy segments include: Gastrointestinal medicines Thyroid treatments Anti-infective drugs Diabetes & cardiovascular therapies These are chronic therapy segments, which generally provide stable demand in the pharmaceutical industry. Financial Strength Market Cap: ₹56,000+ crore ROE: 35% ROCE: 46% Dividend Yield: 1.7–1.8% Almost debt-free balance sheet 👉 High ROE and ROCE indicate strong capital efficiency, which is typical of high-quality pharma MNC companies.

#Post-ClosingCommentary#FundamentalViews#WatchOutFor#EquityResearch#HiddenGems
ABBOTINDIA_2026-04-07_16-26-59.png
1,079 likes·28 comments